3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria

3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria

Graded exercise testing (GXT) is a fundamental evaluative tool in cardiac rehabilitation. Performed with standard electrocardiography or open-circuit cardiopulmonary gas exchange analysis (CPET), exercise testing provides objective functional capacity quantification, identifies ischemic thresholds, guides exercise prescription, and establishes prognostic benchmarks.

---

Clinical Indications & Diagnostic Utility

1. Diagnostic Evaluation of Ischemia: Identifies exercise-induced subendocardial ischemia, anginal thresholds, and asymptomatic repolarization abnormalities.
2. Prognostic Risk Assessment: Quantifies cardiovascular mortality risk using validated indices such as the Duke Treadmill Score (DTS):

$\text{DTS} = \text{Exercise Time (min)} - (5 \times \text{ST Deviation [mm]}) - (4 \times \text{Angina Index})$ (Angina Index: $0 = \text{none}$, $1 = \text{non-limiting}$, $2 = \text{exercise-limiting})

• Low Risk ($\ge +5$): 4-year survival $\approx 99%$
• Moderate Risk ($-10 \text{ to } +4$): 4-year survival $\approx 95%$
• High Risk ($< -11$): 4-year survival $\approx 79%$

1. Functional Capacity Determination: Expressed in metabolic equivalents ($1\text{ MET} = 3.5\text{ mL } O_2/\text{kg/min}$). An aerobic capacity $< 5.0\text{ METs}$ indicates high mortality risk, whereas achieving $\ge 10.0\text{ METs}$ confers an excellent prognosis.
2. Exercise Prescription Baseline: Defines measured peak heart rate ($HR_{\text{peak}}$), peak oxygen uptake ($\dot{V}O_{2\text{peak}}$), and the ischemic threshold (workload/heart rate producing $1.0\text{ mm}$ ST depression or angina) to set training intensities safely below ischemic levels.
3. Therapeutic and Device Efficacy: Evaluates beta-blocker blunting and validates rate-adaptive pacemaker responsiveness.

---

Graded Exercise Testing Protocols

Protocol selection must match the patient's functional mobility and clinical stability. Aggressive protocols cause premature test termination due to localized musculoskeletal fatigue rather than true cardiopulmonary limitation.

---

Cardiopulmonary Exercise Testing (CPET) & Gas Exchange

CPET incorporates breath-by-breath analysis of oxygen uptake ($\dot{V}O_2$) and carbon dioxide output ($\dot{V}CO_2$), providing definitive objective measures of cardiorespiratory performance:

• Peak Oxygen Uptake ($\dot{V}O_{2\text{peak}}$): Gold standard of cardiopulmonary fitness. In heart failure with reduced ejection fraction (HFrEF), a $\dot{V}O_{2\text{peak}} < 14\text{ mL/kg/min}$ (or $< 12\text{ mL/kg/min}$ on beta-blockers) serves as a primary criterion for cardiac transplantation referral.
• Respiratory Exchange Ratio (RER): $\text{RER} = \dot{V}CO_2 / \dot{V}O_2$. During low workloads, RER is $0.80\text{--}0.85$. As lactic acid is buffered by bicarbonate, excess non-metabolic $CO_2$ is exhaled. An $\text{RER} \ge 1.10$ verifies a physiologically valid maximal aerobic effort.
• Ventilatory Anaerobic Threshold (VAT / $VT_1$): The point during incremental exercise where blood lactate begins to accumulate above resting levels ($50%\text{--}60%$ of $\dot{V}O_{2\text{peak}}$), identified by a disproportionate rise in $\dot{V}CO_2$ relative to $\dot{V}O_2$ (V-slope) and an increase in $\dot{V}_E/\dot{V}O_2$ without an increase in $\dot{V}_E/\dot{V}CO_2$.
• Respiratory Compensation Point (RCP / $VT_2$): Occurs at $70%\text{--}85%$ of $\dot{V}O_{2\text{peak}}$, where severe lactic acidosis triggers hyperventilation, marked by an increase in $\dot{V}E/\dot{V}CO_2$ and a fall in end-tidal carbon dioxide ($P{ET}CO_2$).
• Ventilatory Efficiency ($\dot{V}_E/\dot{V}CO_2$ Slope): Reflects ventilation-perfusion matching in the lungs. Normal values are $20\text{--}30$. A $\dot{V}_E/\dot{V}CO_2\text{ slope} > 34$ indicates severe ventilatory inefficiency, elevated pulmonary vascular pressures, and markedly increased mortality in heart failure.
• Oxygen Pulse ($\dot{V}O_2 / HR$): Milliliters of oxygen extracted per heart beat. Serves as an indirect surrogate for stroke volume; flattening or decline during exercise indicates left ventricular systolic dysfunction or ischemia.

---

Indications for Terminating a Graded Exercise Test

ACSM and AHA guidelines classify exercise test termination criteria into absolute and relative indications:

graph TD
    GXT["Graded Exercise Test Monitoring"] --> EVAL{"Evaluate Hemodynamics, Symptoms & ECG"}
    EVAL -->|Absolute Criteria Present| STOP["ABSOLUTE TERMINATION<br/>Immediate test cessation<br/>Supine/seated recovery<br/>Alert supervising physician"]
    EVAL -->|Relative Criteria Present| JUDGE["RELATIVE TERMINATION<br/>Clinical judgment<br/>Balance safety vs diagnostic yield<br/>Stop if patient distressed"]

Absolute Indications for Test Termination

(Stop exercise immediately; transfer to recovery and initiate clinical intervention)

1. ST-Segment Elevation: $> 1.0\text{ mm}$ in leads without preexisting diagnostic Q waves (other than $V_1$ or aVR).
2. Exertional Hypotension with Ischemia: Drop in SBP $> 10\text{ mmHg}$ below baseline or from a preceding stage despite increased workload, accompanied by other evidence of ischemia (ST depression or angina).
3. Moderate-to-Severe Angina: $\ge 3$ on the standard 4-point angina scale.
4. Central Nervous System Signs: Ataxia, dizziness, presyncope, mental confusion, or near-syncope.
5. Signs of Poor Perfusion: Cyanosis, pallor, or cold, clammy skin.
6. Sustained Life-Threatening Dysrhythmias: Sustained VT, ventricular fibrillation, second-degree Mobitz II block, or complete AV block.
7. Technical Difficulties: Inability to monitor the ECG or obtain blood pressure readings.
8. Subject Requests to Stop: Patient demands test cessation.

Relative Indications for Test Termination

(Weigh diagnostic value against patient risk; test may be terminated based on clinician discretion)

1. Exertional Hypotension without Ischemia: Drop in SBP $> 10\text{ mmHg}$ with increased workload in the absence of other ischemic evidence.
2. Marked ST-Segment Depression: $> 2.0\text{ mm}$ horizontal or downsloping ST depression.
3. Non-Sustained Arrhythmias: Multifocal PVCs, triplets, SVT, or bradyarrhythmias with potential hemodynamic compromise.
4. Limiting Symptoms: Severe shortness of breath, wheezing, leg fatigue, or claudication.
5. Conduction Defect Development: New bundle branch block that cannot be distinguished from ventricular tachycardia.
6. Exaggerated Hypertensive Response: Systolic blood pressure $> 250\text{ mmHg}$ and/or diastolic blood pressure $> 115\text{ mmHg}$.